Prodrugs
    1.
    发明授权
    Prodrugs 有权
    前药

    公开(公告)号:US08642555B2

    公开(公告)日:2014-02-04

    申请号:US13255812

    申请日:2010-03-09

    IPC分类号: A61K38/08

    摘要: The present invention relates to a prodrug comprising at least one cytostatic agent, wherein said prodrug is cleavable by prostate-specific antigen (PSA), a process for preparing said prodrug and a pharmaceutical composition containing said prodrug in a pharmaceutically effective amount, for use in the treatment of cancer.

    摘要翻译: 本发明涉及包含至少一种细胞生长抑制剂的前体药物,其中所述前体药物可由前列腺特异性抗原(PSA)切割,制备所述前体药物的方法和药物组合物,所述药物组合物含有药学有效量的所述前体药物, 治疗癌症。

    PRODRUGS
    2.
    发明申请
    PRODRUGS 有权

    公开(公告)号:US20120094892A1

    公开(公告)日:2012-04-19

    申请号:US13255812

    申请日:2010-03-09

    摘要: The present invention relates to a prodrug comprising at least one cytostatic agent, wherein said prodrug is cleavable by prostate-specific antigen (PSA), a process for preparing said prodrug and a pharmaceutical composition containing said prodrug in a pharmaceutically effective amount, for use in the treatment of cancer.

    摘要翻译: 本发明涉及包含至少一种细胞生长抑制剂的前体药物,其中所述前体药物可由前列腺特异性抗原(PSA)切割,制备所述前体药物的方法和药物组合物,所述药物组合物含有药学有效量的所述前体药物, 治疗癌症。

    PROTEIN-BINDING METHOTREXATE DERIVATIVES, AND MEDICAMENTS CONTAINING THE SAME
    3.
    发明申请
    PROTEIN-BINDING METHOTREXATE DERIVATIVES, AND MEDICAMENTS CONTAINING THE SAME 审中-公开
    蛋白质结合甲基衍生物和含有它们的药物

    公开(公告)号:US20100041615A1

    公开(公告)日:2010-02-18

    申请号:US12375406

    申请日:2007-07-25

    IPC分类号: A61K38/07 C07K5/10

    CPC分类号: C07K7/06 A61K47/65 C07K5/1008

    摘要: The invention relates to methotrexate derivatives which contain a protein-binding group and can be enzymatically cleaved in the body such that the active substance or a low-molecular active substance derivative is released. Also disclosed is a method for producing methotrexate derivatives, the use thereof, and medicaments comprising methotrexate derivative.

    摘要翻译: 本发明涉及含有蛋白质结合基团的氨甲蝶呤衍生物,并且可以在体内酶促切割以释放活性物质或低分子活性物质衍生物。 还公开了一种生产甲氨蝶呤衍生物的方法及其用途,以及包含甲氨蝶呤衍生物的药物。